KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intel (INTC) Current Deferred Revenue: 2009-2022

Historic Current Deferred Revenue for Intel (INTC) over the last 14 years, with Q4 2022 value amounting to $20.0 million.

  • Intel's Current Deferred Revenue fell 5348.84% to $20.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $20.0 million, marking a year-over-year decrease of 5348.84%. This contributed to the annual value of $20.0 million for FY2022, which is 5348.84% down from last year.
  • Intel's Current Deferred Revenue amounted to $20.0 million in Q4 2022, which was down 5348.84% from $43.0 million recorded in Q4 2021.
  • In the past 5 years, Intel's Current Deferred Revenue ranged from a high of $2.8 billion in Q1 2018 and a low of $20.0 million during Q4 2022
  • In the last 5 years, Intel's Current Deferred Revenue had a median value of $2.0 billion in 2020 and averaged $1.7 billion.
  • In the last 5 years, Intel's Current Deferred Revenue soared by 7763.07% in 2018 and then tumbled by 9773.68% in 2021.
  • Over the past 5 years, Intel's Current Deferred Revenue (Quarter) stood at $2.7 billion in 2018, then fell by 24.66% to $2.0 billion in 2019, then decreased by 6.91% to $1.9 billion in 2020, then plummeted by 97.74% to $43.0 million in 2021, then plummeted by 53.49% to $20.0 million in 2022.
  • Its Current Deferred Revenue stands at $20.0 million for Q4 2022, versus $43.0 million for Q4 2021 and $351.0 million for Q3 2021.